Technical Analysis for PSNL - Personalis, Inc.

Grade Last Price % Change Price Change
C 1.63 1.24% 0.02
PSNL closed up 1.24 percent on Monday, March 18, 2024, on 54 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to bounce off of its 200 day moving average, an important long-term support line.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Crossed Above 200 DMA Bullish 1.24%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.24%
NR7 Range Contraction 1.24%
Inside Day Range Contraction 1.24%
Wide Bands Range Expansion 1.24%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 10 hours ago
Down 1% about 10 hours ago
Fell Below 200 DMA about 11 hours ago
60 Minute Opening Range Breakdown about 12 hours ago
200 DMA Support about 13 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves approximately 45 biopharmaceutical customers, including a range of pharmaceutical companies. The company was founded in 2011 and is headquartered in Menlo Park, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmaceutical Biology Telehealth Telemedicine Genomics Medical Genetics Molecular Diagnostics Applied Genetics Cancer Therapies Analysis Services Biopsy Cancer Therapy Data Analysis Services Treating Cancer Oncogenomics

Is PSNL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.26
52 Week Low 0.8912
Average Volume 427,480
200-Day Moving Average 1.60
50-Day Moving Average 1.53
20-Day Moving Average 1.56
10-Day Moving Average 1.67
Average True Range 0.15
RSI (14) 54.34
ADX 27.1
+DI 19.25
-DI 13.65
Chandelier Exit (Long, 3 ATRs) 1.35
Chandelier Exit (Short, 3 ATRs) 1.64
Upper Bollinger Bands 1.91
Lower Bollinger Band 1.21
Percent B (%b) 0.6
BandWidth 44.32
MACD Line 0.06
MACD Signal Line 0.06
MACD Histogram 0.0012
Fundamentals Value
Market Cap 79.92 Million
Num Shares 49 Million
EPS -2.38
Price-to-Earnings (P/E) Ratio -0.68
Price-to-Sales 0.83
Price-to-Book 0.39
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.73
Resistance 3 (R3) 1.73 1.70 1.72
Resistance 2 (R2) 1.70 1.67 1.70 1.71
Resistance 1 (R1) 1.66 1.65 1.68 1.66 1.71
Pivot Point 1.63 1.63 1.63 1.63 1.63
Support 1 (S1) 1.59 1.60 1.61 1.60 1.55
Support 2 (S2) 1.56 1.58 1.56 1.55
Support 3 (S3) 1.52 1.56 1.54
Support 4 (S4) 1.53